Macrocyclic Radiopharmaceutical Ligands for Stable Copper Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing radiolabelled compounds face issues with metal ion dissociation in physiological environments, leading to reduced delivery to target sites and increased side effects due to distribution to healthy tissues, and current methods for attaching molecular recognition moieties to ligands are inefficient and prone to impurities or unwanted side reactions.
Innovation Solution
Development of nitrogen-containing macrocyclic metal ligands with a linking moiety and molecular recognition moiety, allowing for stable complex formation and efficient targeting, using compounds of formula (I) and (II) that incorporate amino acid spacers to attach molecular recognition moieties without compromising stability, and methods for their synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If simple metal ligands are used for radiopharmaceuticals, then ease of manufacture is improved, but stability of the complex is worsened leading to metal ion dissociation
Solution Approach 1:
The patent employs composite ligand structures combining macrocyclic frameworks (such as cyclam or cyclen) with pendant functional groups (carboxymethyl, hydroxymethyl, or aminoalkyl groups). This composite approach creates ligands that form exceptionally stable complexes with copper ions while maintaining synthetic accessibility through established organic synthesis methods.
Solution Approach 2:
The ligand design features a nested structure where a macrocyclic ring system provides the primary coordination sphere for the metal ion, while pendant functional groups extend outward to provide additional coordination sites and functionalization points. This nested architecture enhances complex stability without significantly complicating the synthesis pathway.
2Stability of the object's composition
If more complicated ligands are used to prevent metal dissociation, then stability of the complex is improved, but device complexity is worsened
Solution Approach 1:
The ligand is segmented into distinct functional domains: a macrocyclic core (cyclam or cyclen) that provides rigid structural support and primary metal coordination, and pendant arms (carboxymethyl, hydroxymethyl, or aminoalkyl groups) that provide additional coordination and functionalization capability. This segmentation allows each part to perform its specific function optimally while keeping the overall structure manageable.
Solution Approach 2:
Different regions of the ligand possess specialized properties: the macrocyclic nitrogen atoms provide strong field coordination for stability, while the pendant functional groups (particularly carboxymethyl and hydroxymethyl) provide additional coordination sites and points for molecular recognition moiety attachment. This local differentiation of functional properties maximizes complex stability without requiring uniform complexity throughout the entire molecule.
3Productivity
If existing methods are used to attach molecular recognition moieties to ligands, then productivity is maintained, but manufacturing precision is worsened due to impurities and side reactions
Solution Approach 1:
The patent extracts the functionalization capability from the metal coordination sphere by placing reactive functional groups (carboxymethyl, hydroxymethyl, or aminoalkyl groups) on pendant arms that extend away from the metal binding site. This spatial separation allows molecular recognition moieties to be attached to the pendant groups without interfering with the metal-ligand complex formation, thereby maintaining both high productivity and manufacturing precision.
Solution Approach 2:
The pendant functional groups (particularly carboxymethyl and hydroxymethyl groups) serve as intermediary attachment points between the metal-chelating macrocyclic core and the molecular recognition moieties. These intermediary groups provide chemoselective reaction sites that enable efficient conjugation while preventing unwanted side reactions at the metal coordination sites, thus maintaining both productivity and manufacturing precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds achieve enhanced stability and targeting ability, enabling effective delivery of radiopharmaceuticals to specific sites with reduced side effects and improved biological activity, particularly suitable for copper-based radiopharmaceuticals.
Implementation Method 1
the complex formed between the ligand and the metal ion was not sufficiently strong and so dissociation of the metal ion from the ligand occurred
Data Source
AI summary
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated with a suitable metallic radionuclide, the coordinated compounds are useful as radiopharmaceuticals in the areas of radiotherapy and diagnostic imaging. The invention therefore also relates to methods of diagnosis and therapy utilising the radiolabelled compounds of the invention.